Adjuvant treatment improves overall survival in women with high-intermediate risk early-stage endometrial cancer with lymphovascular space invasion.
Ji SonLaura M ChambersCaitlin CarrChad M MichenerMeng YaoAnna BeavisTing-Tai YenRebecca L StoneStephanie L WethingtonAmanda N FaderWesley C BurkettDebra L RichardsonAllison S StaleySusie AhnPaola A GehrigDiogo TorresSean C DowdyMackenzie W SullivanSusan C ModesittCatherine WatsonAshley VeadeJessie EhrismanLaura HavrileskyAngeles Alvarez SecordAmy LoreenKaitlyn GriffinAmanda JacksonAkila N ViswanathanStephanie RicciPublished in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2020)
Adjuvant therapy improves both progression-free survival and overall survival in women with early-stage endometrial cancer meeting high-intermediate risk criteria with lymphovascular space invasion. External beam radiation or adding chemotherapy did not confer additional survival advantage compared with vaginal brachytherapy alone.